Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Insight & Intelligence™

Related to Evotec Pays €10.25M for Galapagos’ Compound-Management Business

  • Studies Suggest that When It Comes to Drug Development Success, Size Matters
    Higher percentage of large molecules compared to small molecules makes it to market.
  • Resolving Pharmacological Responses
    A new microfluidic approach can dramatically increase the number of data points per compound during screening.
  • A SPA for PMTs
    Researchers propose a SPA strategy that can be successfully implemented to identify novel and specific inhibitors of PMTs.
  • New Luciferins
    Researchers describe a rapid method to synthesize D-luciferin along with a novel set of electronically modified analogues.
  • Biographies for Compounds
    Researchers demonstrate the value of a tool that compares compounds solely on the basis of their bioactivity for virtual screening.
  • Binding MoA by DPI
    Researchers investigate the application of dual-polarization interferometry (DPI) as a method for the real-time characterization of low molecular weight ligands.
  • Page 1 of 1 (6 items) 1 

GEN Poll

More » Poll Results » Archive »

Myriad Genetics Trial: Your Thoughts?

Do you agree with the Supreme Court’s decision in the Myriad case?

Suggest a Poll